Cefazolin dosing protocol for patients receiving long-term hemodialysis.
Ahern
John W
JW
Department of Pharmacotherapy, Fletcher Allen Health Care-MCHV Campus, 111 Colchester Avenue, Burlington, VT 05401, USA. john.ahern@vtmednet.org
Possidente
Carl J
CJ
Hood
Virginia
V
Alston
W Kemper
WK
D000368:Aged; D002437:Cefazolin / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D002511:Cephalosporins / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005260:Female; D016908:Gram-Positive Bacterial Infections / Q000097:blood / Q000517:prevention & control; D006745:Hospital Bed Capacity, 300 to 499; D006801:Humans; D008297:Male; D011446:Prospective Studies; D006435:Renal Dialysis
D002511:Cephalosporins; D002437:Cefazolin